6 Cardiac Arrhythmias Nursing Care Plans and Management

Arrhythmias run the full range, from benign and asymptomatic to ventricular fibrillation that needs resuscitation in the next minute. On the floor your job is to catch the rhythm change early, know whether it is dropping cardiac output, and act before the patient codes. Many of these patients are on digoxin, which has a narrow therapeutic window, so toxicity is a constant background risk you screen for at every shift.

What are cardiac dysrhythmias?

Cardiac arrhythmias (also called dysrhythmias) are abnormal electrical conduction or automaticity that change heart rate and rhythm. They follow a primary cardiac disorder, a systemic condition, an electrolyte imbalance, or drug toxicity. Severity and the effect on cardiac function depend partly on where the rhythm originates (ventricular or supraventricular).

Nursing Care Plans and Management

Care planning for arrhythmia from digitalis toxicity centers on fast assessment, prompt symptom treatment, and finding the cause.

Nursing Problem Priorities

1. Treat life-threatening dysrhythmias.
2. Identify the cause or precipitating factors.
3. Teach the patient and family.

Nursing Assessment

Assess for the following subjective and objective data:

• Heart rate. Identifies the presence and type of dysrhythmia. Rates outside the normal range point to tachycardia or bradycardia.
• Rhythm. Regular or irregular tells you what you are dealing with.
• Blood pressure. Shows hemodynamic stability. Dysrhythmias impair cardiac output and drive BP up or down.

Assess for factors related to the cause:

• Altered electrical conduction
• Reduced myocardial contractility

Nursing Diagnosis

• Decreased cardiac output

Nursing Goals

1. The patient maintains adequate cardiac output: BP and pulse in normal range, adequate urine output, palpable pulses of equal quality, normal mentation.
2. The patient has reduced or absent dysrhythmias.
3. The patient engages in activities that lower cardiac workload.
4. The patient understands their medications, including interactions, and the importance of adherence.
5. The patient identifies signs of digitalis overdose and developing heart failure and reports them promptly.
6. The patient shows no signs of drug toxicity and keeps serum drug levels within their individual range.
7. If using a pacemaker, the patient understands their condition, prognosis, and how the pacemaker works.
8. The patient recognizes signs of pacemaker failure.
9. The patient verbalizes understanding of the therapeutic regimen.
10. The patient lists the desired actions and adverse effects of their medications.
11. The patient performs necessary procedures correctly and explains why.

Nursing Interventions and Actions

1. Managing Impaired Cardiac Function
2. Monitoring Diagnostic Procedures and Laboratory Studies
3. Administering Medications and Pharmacological Interventions
4. Preventing Digitalis Toxicity and Poisoning
5. Reducing Anxiety
6. Providing Perioperative Nursing Care
7. Providing Patient Education and Health Teachings

1. Managing Impaired Cardiac Function

An irregular rhythm cuts the heart's ability to pump, dropping oxygen and blood flow to vital organs. Managing the dysrhythmia protects cardiac output.

1. Palpate pulses (radial, carotid, femoral, dorsalis pedis), noting rate, regularity, amplitude (full or thready), and symmetry. Document pulsus alternans, bigeminal pulse, or pulse deficit. Differences in pulse equality, rate, and regularity show how altered cardiac output is hitting systemic and peripheral circulation.

2. Auscultate heart sounds, noting rate, rhythm, extra heartbeats, and dropped beats. Some dysrhythmias are easier to hear than to feel. Extra or dropped beats flag a dysrhythmia in the unmonitored patient.

3. Monitor vital signs and the adequacy of cardiac output and tissue perfusion. Note significant variations in BP and pulse rate, respirations, skin color and temperature, level of consciousness, and urine output during dysrhythmia episodes. Not every dysrhythmia is lethal, but a dysrhythmia that drops cardiac output and perfusion needs immediate treatment.

4. Investigate chest pain, documenting location, duration, intensity (0 to 10 scale), and relieving or aggravating factors. Note nonverbal cues: grimacing, crying, BP and heart rate changes. Chest pain can mean ischemia from altered conduction, decreased myocardial perfusion, or increased oxygen demand.

5. Be ready to start CPR. Life-threatening dysrhythmias need prompt intervention to prevent ischemic damage and death.

6. Insert and maintain IV access. A patent line may be needed for emergency drugs.

7. Administer antiarrhythmic medications as ordered. See Pharmacologic Management.

2. Monitoring Diagnostic Procedures and Laboratory Studies

Tracking diagnostics and labs lets the team adjust drugs, gauge response, and head off complications.

1. Determine the dysrhythmia type and document it with a rhythm strip when telemetry is available.

• Sinus tachycardia. Occurs with stress, pain, fever, infection, coronary blockage, valvular dysfunction, hypovolemia, hypoxia, decreased vagal tone, or catecholamine release. Usually needs no treatment, but persistent tachycardia worsens ischemic heart disease through shortened diastolic filling and higher oxygen demand, and may need medication.
• Sinus bradycardia. Common in acute MI (especially anterior and inferior) from excess parasympathetic activity, SA or AV conduction block, or loss of automaticity. Patients with severe heart disease cannot always compensate with stroke volume, so decreased cardiac output, HF, and lethal ventricular dysrhythmias can follow.
• Atrial dysrhythmias. Premature atrial contractions (PACs) often respond to ischemia, are usually harmless, but can precede atrial fibrillation. Atrial flutter and fibrillation (the most common dysrhythmia) occur with coronary or valvular disease. Atrial supraventricular tachycardias (PAT, MAT, SVT) reduce cardiac output through incomplete ventricular filling and raise oxygen demand.
• Ventricular dysrhythmias. PVCs reflect cardiac irritability and are tied to MI, digitalis toxicity, coronary vasospasm, and misplaced pacemaker leads. Frequent, multiple, or multifocal PVCs drop cardiac output and can trigger VT, ventricular flutter or fibrillation, and sudden death. Polymorphic VT (torsades de pointes) shows inconsistent QRS shapes and is often drug-related: procainamide (Pronestyl), quinidine (Quinaglute), disopyramide (Norpace), and sotalol (Betapace). Heart blocks bring slowed ventricular rates, decreased cardiac output, and the risk of lethal arrhythmias or cardiac standstill.

2. Monitor laboratory studies.

• Electrolytes. Potassium, magnesium, and calcium imbalances disrupt conduction and contractility and provoke abnormal rhythms.
• Drug levels. Reveal therapeutic or toxic levels of prescription drugs or street drugs contributing to the dysrhythmia.

3. Prepare for and assist with elective cardioversion. Used in atrial fibrillation and certain unstable dysrhythmias to restore rate and relieve heart failure symptoms.

3. Administering Medications and Pharmacological Interventions

Medications control rhythm, prevent clots, and lower the risk of stroke and other complications. Watch the response closely to confirm the plan is working.

1. Give supplemental oxygen as indicated. More oxygen for myocardial uptake reduces the irritability hypoxia causes.

2. Potassium. Correcting hypokalemia can terminate some ventricular dysrhythmias. Potassium imbalance is the leading cause of atrial fibrillation.

3. Antidysrhythmics. These regulate rhythm and treat the various arrhythmias.

• Class I. Depress depolarization and alter repolarization to stabilize the cell. Subdivided into Ia, Ib, and Ic, they increase action potential duration and the effective refractory period, prolonging QRS and QT. Useful for atrial and ventricular premature beats and repetitive arrhythmias. Myocardial depression worsens when class Ia drugs are combined with similar agents.
  • Class Ia: disopyramide (Norpace), procainamide (Pronestyl, Procan SR), quinidine (Quinaglute, Cardioquin). Shorten the refractory period (QT interval); action depends on the tissue and extracellular potassium.
  • Class Ib: lidocaine (Xylocaine), phenytoin (Dilantin), tocainide (Tonocard), mexiletine (Mexitil), moricizine (Ethmozine). Drugs of choice for ventricular dysrhythmias and digitalis-induced dysrhythmias. May aggravate myocardial depression.
  • Class Ic: flecainide (Tambocor), propafenone (Rythmol), encainide (Enkaid). Slow conduction by depressing SA node automaticity and slowing conduction through atria, ventricles, and Purkinje fibers, prolonging the PR interval and QRS. Suppress all types of ventricular dysrhythmias. Flecainide raises the risk of drug-induced dysrhythmias post-MI. Propafenone can cause new dysrhythmias (the proarrhythmic effect). Encainide is restricted to patients who responded before it was pulled from the market.
• Class II: atenolol (Tenormin), propranolol (Inderal), nadolol (Corgard), acebutolol (Sectral), esmolol (Brevibloc), sotalol (Betapace), bisoprolol (Zebeta). Beta-blockers decrease automaticity and treat dysrhythmias from SA and AV node dysfunction (SVTs, atrial flutter or fibrillation). Can worsen bradycardia and cause myocardial depression, especially with similar drugs.
• Class III: bretylium tosylate (Bretylol), amiodarone (Cordarone), sotalol (Betapace), ibutilide (Corvert). Prolong the refractory period, action potential duration, and QT interval. Used for ventricular fibrillation and life-threatening or sustained ventricular tachyarrhythmias when lidocaine and procainamide fail. Sotalol is a nonselective beta-blocker with class II and class III properties.
• Class IV: verapamil (Calan), nifedipine (Procardia), diltiazem (Cardizem). Calcium channel blockers slow AV conduction (prolonging PR) to decrease ventricular response in SVTs and atrial flutter or fibrillation. Calan and Cardizem can be used for bedside conversion of acute atrial fibrillation.
• Class V: atropine sulfate, isoproterenol (Isuprel). Treat bradycardia by increasing SA and AV conduction and enhancing automaticity.

4. Cardiac glycosides: digoxin (Lanoxin). Used alone or with other antiarrhythmics to slow ventricular rate in uncontrolled or poorly tolerated atrial tachycardias, flutter, and fibrillation. First-line for paroxysmal supraventricular tachycardia.

5. Adenosine (Adenocard). Slows conduction and interrupts reentry in the AV node. Contraindicated in second or third-degree heart block, or sick sinus syndrome without a functioning pacemaker.

4. Preventing Digitalis Toxicity and Poisoning

Digoxin has a narrow therapeutic window, and up to 15% of patients on it develop toxicity at some point. Toxicity brings nausea, vomiting, and dangerous arrhythmias, so screen levels and symptoms every shift.

1. Order periodic lab evaluation.

• Serum digoxin (Lanoxin) or digitoxin (Crystodigin) level. Read alongside clinical signs and ECG to set the individual therapeutic level or confirm resolution of toxicity.
• Electrolytes, BUN, creatinine, liver function studies. Abnormal potassium, calcium, or magnesium increases sensitivity to digitalis. Impaired kidneys let digoxin (renally excreted) accumulate; impaired liver affects digitoxin (excreted by the bowel).

2. Explain the specific digitalis preparation and its use. Preparations vary in name, dosage strength, and onset and duration, which causes confusion.

3. Instruct the patient not to change, omit, increase, or double a dose, and to call the provider if more than one dose is missed. Regimen changes reduce effect, cause toxicity, and bring complications.

4. Warn that digitalis interacts with many drugs (barbiturates, neomycin, cholestyramine, quinidine, antacids). Tell every new prescriber that digitalis is on board, and clear any OTC drug (laxatives, antidiarrheals, antacids, cold remedies, diuretics, herbals) with the pharmacist or provider first. Prevents dangerous interactions.

5. Review dietary and supplemental potassium, calcium, and magnesium. Normal electrolytes prevent or limit toxicity and correct associated dysrhythmias.

6. Have the patient or family verbalize the toxic signs to report. Nausea, vomiting, diarrhea, unusual drowsiness, confusion, very slow or very fast irregular pulse, thumping in the chest, double or blurred vision, yellow or green tint or halos, flickering colors or dots, altered color perception, and worsening heart failure (edema, dyspnea, decreased voiding) all need prompt evaluation. Mild toxicity may be managed with a brief drug holiday. In severe or refractory heart failure, altered cardiac binding of digitalis can cause toxicity even at previously appropriate doses.

7. Administer additional medications as appropriate: lidocaine (Xylocaine), propranolol (Inderal), procainamide (Pronestyl), and digoxin immune Fab (Digibind). Support cardiac output against excess digitalis effects. Digoxin immune Fab increases drug excretion in acute or severe toxicity when standard therapy fails.

8. Prepare for transfer to CCU as indicated (dangerous dysrhythmias, worsening heart failure). Digitalis toxicity often needs intensive monitoring until levels normalize. All digitalis preparations have long half-lives, so stabilization can take several days.

5. Reducing Anxiety

Anxiety releases catecholamines that worsen arrhythmias, so keeping the patient calm is part of rhythm control.

1. Provide a quiet, calm environment and review why activity is limited during the acute phase. Reduces catecholamine release that triggers dysrhythmias and vasoconstriction and raises myocardial workload.

2. Teach and encourage stress management: relaxation, guided imagery, slow deep breathing. Gives the patient some sense of control in a stressful situation.

6. Providing Perioperative Nursing Care

Arrhythmia patients are at higher risk of exacerbation during surgery, so monitor closely and intervene early.

1. Assist with pacemaker insertion and maintenance. Temporary pacing accelerates impulse formation or overrides tachydysrhythmias and ectopy until spontaneous or permanent pacing takes over.

2. Prepare for invasive diagnostics and surgery as indicated. A differential diagnosis may be needed to set the plan. Ventricular aneurysm resection corrects intractable ventricular dysrhythmias unresponsive to drugs. CABG may improve circulation to the myocardium and conduction system.

3. Prepare for implantation of a cardioverter-defibrillator (ICD) when indicated. Surgically implanted for recurrent, life-threatening ventricular dysrhythmias that fail drug therapy. Current devices deliver tiered therapy: antitachycardia and antibradycardia pacing, cardioversion, or defibrillation, depending on programming.

7. Providing Patient Education and Health Teachings

Patients and families need to understand the condition, its management, and the warning signs. Teaching them turns them into active partners and a second set of eyes.

1. Assess the patient's and family's knowledge, ability, and desire to learn. Drives the individual teaching plan. Verbalization surfaces misunderstandings for correction.

2. Watch for avoidance: changing the subject or extremes of behavior (withdrawal or euphoria). Anger and denial block learning. A less formal style may work better until the patient and family are ready.

3. Present information in varied formats: written material, audiovisual, question-and-answer, group activities. Multiple methods improve retention.

4. Provide written instructions to take home. A followup resource for when the patient is away from the team.

5. Reinforce risk factors, dietary and activity restrictions, medications, and symptoms needing immediate attention. Lets the patient retain information and participate in rehab.

6. Encourage reduction of individual risk factors: smoking, alcohol, obesity. These directly harm cardiovascular function. Smoking raises arrhythmia risk by damaging the heart and vessels, raising heart rate and BP, and cutting oxygen supply.

7. Review normal cardiac function and electrical conduction. Gives the patient a base to understand their therapy and to recognize and report rhythm changes.

8. Explain the patient's specific dysrhythmia and therapeutic measures. Reduces anxiety and prepares the patient and family for lifestyle changes. Teaching the family matters most when the patient is elderly, sensory-impaired, or unable to follow instructions. Repeat as needed, since anxiety and information overload block learning.

9. Identify adverse effects and complications: fatigue, dependent edema, changes in mentation, vertigo. These signal developing cardiac failure or altered cerebral perfusion. Tachydysrhythmias can also bring debilitating anxiety and a sense of impending doom.

10. Document medication teaching: why the drug is needed, how and when to take it, what to do for a missed dose, and expected side effects and interactions with other drugs, alcohol, tobacco, and herbals, plus what to report. Herbal remedies with the drug regimen can cause cardiac stimulation and impaired clotting, so evaluate any product for safe use.

11. Encourage a regular exercise routine without overexertion. Teach the signs that mean stop: dizziness, lightheadedness, dyspnea, chest pain. Well-managed dysrhythmias should not limit normal activity, and exercise improves cardiovascular health.

12. Review dietary needs and restrictions: potassium, caffeine. Patients on potassium-depleting diuretics may need more dietary potassium. Limit caffeine to prevent cardiac excitation and palpitations.

13. Teach pulse-taking. Recommend a weekly pulse check for 1 full minute, or a daily pulse before medication and during exercise. Identify what needs immediate care: dizziness, irregular heartbeat, fainting, chest pain. Self-monitoring catches problems early. The regimen may be adjusted when the rate strays from the target or the pacemaker's preset rate.

14. Review safety precautions and how to evaluate and maintain pacemaker or ICD function, and symptoms needing care: a pulse below the set limit for demand pacing or below the low-limit rate for rate-adaptive pacers, and prolonged hiccups. Promotes self-care and timely intervention. Instructions depend on the device type and the patient's support.

15. Recommend a medical alert bracelet or necklace and a pacemaker ID card. Allows fast, appropriate care if the patient cannot respond in an emergency.

16. Discuss environmental safety. Microwaves and household appliances (electric blankets, razors, radio, TV) are safe if properly grounded and in good repair. Metal detectors are fine, though pacemakers may trigger sensitive ones. Cordless phones are safe; a cell phone held directly over a pacemaker can interfere, so do not carry a phone in a shirt pocket while it is on. Avoid high-voltage areas, strong magnetic fields, and radiation: high-tension wires, arc welding, large industrial magnets, demolition sites, and MRI. Clears up misconceptions and helps the patient avoid harm.